1
10 Views
Evidence that it may be a clinical strategy to use MEK inhibitors to treat metastatic uveal melanomas. However, the same issues of a lack of correlation between the in vitro and clinical results when blocking oncogenic MAPK signaling using MEK inhibitors may apply to uveal melanomas. The differential uptake of 3H-radiolabeled compounds that are trapped intracellularly upon metabolic processing all
Newsletter
Sign up for our newsletter


Unsubscribe at Anytime | Privacy Policy
Welcome, DisDroidians

Sign up and post your links!

sponsored
Most Viewed Stories
Latest Comments
Statistics
Disdroid.co.uk - ranking and value